Analyst Ratings For Novo Nordisk
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Novo Nordisk (NYSE:NVO) over the past three months, with a consistent 'Somewhat Bullish' sentiment. The average 12-month price target is $160, slightly down from the previous $161.43. Novo Nordisk shows strong financial performance with significant revenue growth and high net margins.
October 10, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have maintained a 'Somewhat Bullish' rating on Novo Nordisk with a consistent price target of $160. The company's strong financial performance, including a 25.34% revenue growth and a 29.46% net margin, supports this sentiment.
The consistent 'Somewhat Bullish' ratings and stable price target of $160 suggest positive sentiment among analysts. Novo Nordisk's strong financial metrics, such as high revenue growth and net margin, further bolster the stock's outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100